N(1)-methyladenosine modification in cancer biology: Current status and future perspectives

癌症生物学中的N(1)-甲基腺苷修饰:现状与展望

阅读:2

Abstract

Post-transcriptional modifications in RNAs regulate their biological behaviors and functions. N(1)-methyladenosine (m(1)A), which is dynamically regulated by writers, erasers and readers, has been found as a reversible modification in tRNA, mRNA, rRNA and long non-coding RNA (lncRNA). m(1)A modification has impacts on the RNA processing, structure and functions of targets. Increasing studies reveal the critical roles of m(1)A modification and its regulators in tumorigenesis. Due to the positive relevance between m(1)A and cancer development, targeting m(1)A modification and m(1)A-related regulators has been of attention. In this review, we summarized the current understanding of m(1)A in RNAs, covering the modulation of m(1)A modification in cancer biology, as well as the possibility of targeting m(1)A modification as a potential target for cancer diagnosis and therapy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。